How Lung Cancer Spreads and What It Means for Treatment
Did you know nearly 60% of people with lung cancer will see it spread? This fact highlights why it’s so […]
Immunotherapy breakthroughs
Durvalumab Lung Cancer Survival Rate Latest Research
Did you know that durvalumab can significantly help patients with stage III lung cancer? Recent studies show these patients have
Immunotherapy Success Rate for Lung Cancer: Latest Data
Did you know that the survival rate for all types of non-small cell lung cancer (NSCLC) has gone up greatly?
Immunotherapy for Small Cell Lung Cancer: Latest Options
For over thirty years, the fight against small-cell lung cancer (SCLC) hasn’t seen much change. But now, there’s hope with
Immunotherapy for Metastatic Lung Cancer: New Hope
In a recent study of more than 197,000 patients with stage IV non-small cell lung cancer (NSCLC), about 7.3% started
Immunotherapy for Small Cell Lung Cancer Treatment
Did you know in the ADRIATIC trial, over 57% of people taking durvalumab were still alive after three years? This